September FOCUS Newsletter
MONSANTO ACQUIRES TARGETED-PEST CONTROL TECHNOLOGY START-UP
ST. LOUIS (Sept. 28, 2011) – Monsanto Company (NYSE: MON) today announced it has acquired Beeologics, which researches and develops biological tools to provide targeted control of pests and diseases. Terms of the deal were not disclosed.
New report: The Global Biomedical Industry: Preserving U.S. Leadership
A rare biotech IPO: Clovis hopes for $149.5M
Denver Business Journal by Greg Avery
Colorado biotechs court financing by showing off inventions
By Steve Raabe
The Denver Post
Consulate General of Canada Hosts Canadian Bioscience Companies
DENVER—September 21, 2011—A targeted group of Rocky Mountain investors and senior executives from international companies in the life science industry will have the opportunity to learn more about investment and partnering opportunities with Canadian companies during Colorado BioScience Association’s Second Annual Rocky Mountain Life Science Investor & Partnering Conference. The event will take place on Sept. 21 – 23, 2011, at the Brown Palace Hotel in Denver.
Bioscience firms to make pitches for VC
Innovative Thought Leaders Address the 2011 Rocky Mountain Life Science Conference
The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will host several keynote speakers who are shaping the future of bioscience. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.
w3w3.com Interviews Holli Riebel: 'Challenges and solutions for the Bio and Life Sciences industry'
Quoting from CBSA Pres/CEO's recent interview with w3w3.com's Larry Nelson on the upcoming Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) in Denver:
"The Bio and Life Sciences industry faces huge challenges raising venture capital in a difficult economy. Investing in an industry that takes ten to twelve years and over $1.3 Billion to bring a drug to market just might shift the action to some widget or a software program that can be flipped to realize a return in just six months. That's the challenge facing the Colorado BioScience Association (CBSA) and president/CEO, Holli Riebel. 'Also,' she said, 'venture capitalists reside more on the coasts, and so we're always having a more difficult time attracting venture capital out here in the middle of the country.'"
Link to w3w3.com
Link to download the podcast
Medivance Arctic Sun® Products Are the Preferred Choice of the top 10 Hospitals
The top-10 of the U.S. News & World Report 2011-12 Honor Roll Hospitals are all users of the Medivance® Inc. Targeted Temperature Management™ products. The list, released July 19 online and available on newsstands through November 29, is the most comprehensive annual ranking of the nation's top medical centers.